Evaluate the Efficacy of an Oral Health Behavioral Intervention in People With Diabetes
← catalyst calendarNCT07619729 · readout in 501 d
Sponsored by Colgate Palmolive (industry) · CL — their whole pipeline →.
Phase
Phase 4
Status
Enrolling by invitation
Study type
Interventional
Design
Na · None · Prevention
Enrollment
10,000estimated
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-05-26 | estimated | When the study began enrolling |
| Primary completion | 2028-01-02 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2028-01-02 | estimated | The whole study's end, after follow-up |
| First posted | 2026-06-02 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-03 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Diabetes Type 2
- Periodontal Disease
- Caries
Interventions
- Behavioral: Diabetes Oral Health Program
- Drug: Stannous Fluoride Dentifrice
- Drug: Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash — also filed as CPC + Zn, CPC + Zinc, mouthwash
Primary outcome
what the primary-completion date above is the date OFDental Claims
measured 12 months
Permalink · CL's whole pipeline · Catalyst calendar · Every registered study · What changed